FLR vs ACA
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
FLR · Fluor$43.61 ▼ 4.64%
ACA · Arcosa$149.15 ▲ 0.00%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- FLR +5.3%
- ACA +42.7%
Head to head
| Metric | FLR | ACA |
|---|---|---|
| Price | $43.61 | $149.15 |
| Change today | ▼ 4.64% | ▲ 0.00% |
| Market cap | $5.59B | $7.32B |
| Return, 3 months | -15.0% | +2.9% |
| Return, year to date | +10.0% | +40.5% |
| Return, 1 year | +8.9% | +60.5% |
| P/E (TTM) | – | 15.0 |
| P/B | 2.2 | 2.5 |
| P/E percentile vs own 5y | 39th | 25th |
| Dividend yield | – | 0.13% |
| Revenue growth (YoY, latest qtr) | +10.5% | +1.7% |
| Net profit growth (YoY) | +126.3% | +450.3% |
| Gross margin | 3.3% | 22.8% |
| Operating margin | 2.1% | 12.0% |
| Net margin | -7.2% | 16.8% |
| Return on equity | -29.4% | 17.9% |
| Analyst target vs. price | +34.1% | +0.6% |
| Analyst buy share | 50% | 0% |
| RSI (14) | 35 | 83 |
| 30-day volatility | 48.1% | 3.9% |
| Max drawdown, 1 year | -24.5% | -21.4% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ACA is the largest of the group by market value.
- ACA has returned the most over the past year.
- FLR is growing revenue fastest.
- ACA keeps the most profit per dollar of sales.
- ACA has been the calmest stock over the last 30 days.